Rasmus P. Clausen

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptors.

UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptors.

Journal: bioRxiv : the preprint server for biology

Published: November 26, 2025

UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptors.

UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptors.

Journal: Molecular pharmacology

Published: November 17, 2025

Novel binding mode for negative allosteric NMDA receptor modulators.

Novel binding mode for negative allosteric NMDA receptor modulators.

Journal: The Journal of general physiology

Published: August 19, 2025

Auxiliary subunits reshape structural asymmetry and functional plasticity in heterotetrameric GluA1/A2 AMPA receptor core.

Auxiliary subunits reshape structural asymmetry and functional plasticity in heterotetrameric GluA1/A2 AMPA receptor core.

Journal: Nature communications

Published: August 18, 2025

Design of (R)-3-(5-Thienyl)carboxamido-2-aminopropanoic Acid Derivatives as Novel NMDA Receptor Glycine Site Agonists: Variation in Molecular Geometry to Improve Potency and Augment GluN2 Subunit-Specific Activity.

Design of (R)-3-(5-Thienyl)carboxamido-2-aminopropanoic Acid Derivatives as Novel NMDA Receptor Glycine Site Agonists: Variation in Molecular Geometry to Improve Potency and Augment GluN2 Subunit-Specific Activity.

Journal: Journal of medicinal chemistry

Published: January 23, 2025

Evaluation of allosteric N-methyl-d-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modeling.

Evaluation of allosteric N-methyl-d-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modeling.

Journal: Molecular pharmacology

Published: June 20, 2024

Discovery of (R)-2-amino-3-triazolpropanoic acid derivatives as NMDA receptor glycine site agonists with GluN2 subunit-specific activity.

Discovery of (R)-2-amino-3-triazolpropanoic acid derivatives as NMDA receptor glycine site agonists with GluN2 subunit-specific activity.

Journal: Frontiers in chemistry

Published: July 31, 2022

In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs.

In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs.

Journal: Biological chemistry

Published: July 12, 2022

Derivatives of (R)-3-(5-Furanyl)carboxamido-2-aminopropanoic Acid as Potent NMDA Receptor Glycine Site Agonists with GluN2 Subunit-Specific Activity.

Derivatives of (R)-3-(5-Furanyl)carboxamido-2-aminopropanoic Acid as Potent NMDA Receptor Glycine Site Agonists with GluN2 Subunit-Specific Activity.

Journal: Journal of medicinal chemistry

Published: December 17, 2021

GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain.

GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 31, 2021

Artificial Intelligence and Cheminformatics-Guided Modern Privileged Scaffold Research.

Artificial Intelligence and Cheminformatics-Guided Modern Privileged Scaffold Research.

Journal: Current topics in medicinal chemistry

Published: December 31, 2020

Stereoselective synthesis of novel 2'-(S)-CCG-IV analogues as potent NMDA receptor agonists.

Stereoselective synthesis of novel 2'-(S)-CCG-IV analogues as potent NMDA receptor agonists.

Journal: European journal of medicinal chemistry

Published: September 28, 2020

Showing 1-12 of 57

Last Updated: 09/26/2026